Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Country/Region as subject
Language
Publication year range
1.
Int J Mol Sci ; 22(3)2021 Jan 29.
Article in English | MEDLINE | ID: mdl-33572970

ABSTRACT

MAF1 is a global suppressor of RNA polymerase III-dependent transcription, and is conserved from yeast to human. Growing evidence supports the involvement of MAF1 in the immune response of mammals, but its biological functions in fish are unknown. We isolated and characterized Maf1 from the olive flounder Paralichthys olivaceus (PoMaf1). The coding region of PoMaf1 comprised 738 bp encoding a 245-amino-acid protein. The deduced PoMAF1 amino acid sequence shared features with those of MAF1 orthologues from vertebrates. PoMaf1 mRNA was detected in all tissues examined, and the levels were highest in eye and muscle tissue. The PoMaf1 mRNA level increased during early development. In addition, the PoMaf1 transcript level decreased during viral hemorrhagic septicemia virus (VHSV) infection of flounder hirame natural embryo (HINAE) cells. To investigate the role of PoMaf1 in VHSV infection, single-cell-derived PoMaf1 knockout HINAE cells were generated using the clustered regularly interspaced short palindromic repeats/CRISPR-associated-9 (CRISPR/Cas9) system, and cell clones with complete disruption of PoMaf1 were selected. PoMaf1 disruption increased the VHSV glycoprotein (G) mRNA levels during VHSV infection of HINAE cells, implicating PoMAF1 in the immune response to VSHV infection. To our knowledge, this is the first study to characterize fish Maf1, which may play a role in the response to viral infection.


Subject(s)
Fish Diseases/genetics , Fish Proteins/genetics , Flounder/genetics , Hemorrhagic Septicemia/veterinary , Novirhabdovirus/physiology , Repressor Proteins/genetics , Animals , CRISPR-Cas Systems , Cell Line , Fish Diseases/immunology , Fish Proteins/immunology , Flounder/immunology , Flounder/physiology , Hemorrhagic Septicemia/genetics , Hemorrhagic Septicemia/immunology , Host-Pathogen Interactions , Novirhabdovirus/immunology , Phylogeny , Repressor Proteins/immunology , Transcription, Genetic
2.
Gene ; 826: 146452, 2022 Jun 05.
Article in English | MEDLINE | ID: mdl-35339640

ABSTRACT

Pasteurella multocida, a Gram-negative bacterium with ubiquitous nature, is known to affect wide range of host species worldwide with varied clinical manifestations including haemorrhagic septicaemia (HS) in bovines. Although, HS causing P. multocida strains were identified and characterized by conventional tools and PCR assays, diverse strains are indistinguishable by these tools in the face of disease outbreaks. In this study, draft genomes of three virulent P. multocida serotype B:2 strains (NIVEDIPm32, NIVEDIPm34 and NIVEDIPm35) were analyzed following whole genome sequencing, assembly, annotation and compared them with existing global genomes (n = 43) of bovine origin in the database. Three draft genomes of NIVEDIPm strains consisted of 40-52 contigs with GC content of ∼40.4%. The genome size and predicted genes content was ∼2.3 Mb and 2181-2189, respectively. Besides, the presence of various mobile genetic elements, antimicrobial resistance genes and biofilm related genes suggested their vital roles in virulence; further, adaptation to the host immune system as well as host pathogen interaction. Multi locus sequence analysis based on RIRDC scheme showed the presence of ST122 in all the three strains. wgMLST based phylogenic analysis suggested that HS causing Indian virulent field strains differed geographically and showed diversity from existing HS vaccine strain P52. The phylogenetic tree revealed that North Indian strains share high similarity with strains of Pakistan than South Indian Strain. Notably, a high divergence of SNPs between the HS causing circulating virulent strains of India and current HS vaccine strain P52 suggested an imminent need for relook in to HS vaccination strategy for livestock in India.


Subject(s)
Hemorrhagic Septicemia , Pasteurella Infections , Pasteurella multocida , Animals , Cattle , Comparative Genomic Hybridization , Hemorrhagic Septicemia/genetics , Hemorrhagic Septicemia/microbiology , Hemorrhagic Septicemia/veterinary , Pasteurella Infections/microbiology , Pasteurella Infections/veterinary , Phylogeny , Serogroup
3.
PLoS One ; 10(7): e0130296, 2015.
Article in English | MEDLINE | ID: mdl-26151935

ABSTRACT

Pasteurella multocida is the primary causative agent of a range of economically important diseases in animals, including haemorrhagic septicaemia (HS), a rapidly fatal disease of ungulates. There is limited information available on the diversity of P. multocida strains that cause HS. Therefore, we determined draft genome sequences of ten disease-causing isolates and two vaccine strains and compared these genomes using a range of bioinformatic analyses. The draft genomes of the 12 HS strains were between 2,298,035 and 2,410,300 bp in length. Comparison of these genomes with the North American HS strain, M1404, and other available P. multocida genomes (Pm70, 3480, 36950 and HN06) identified a core set of 1,824 genes. A set of 96 genes was present in all HS isolates and vaccine strains examined in this study, but absent from Pm70, 3480, 36950 and HN06. Moreover, 59 genes were shared only by the Asian B:2 strains. In two Pakistani isolates, genes with high similarity to genes in the integrative and conjugative element, ICEPmu1 from strain 36950 were identified along with a range of other antimicrobial resistance genes. Phylogenetic analysis indicated that the HS strains formed clades based on their country of isolation. Future analysis of the 96 genes unique to the HS isolates will aid the identification of HS-specific virulence attributes and facilitate the development of disease-specific diagnostic tests.


Subject(s)
Cattle Diseases/genetics , Genome, Bacterial , Hemorrhagic Septicemia/genetics , Pasteurella multocida/genetics , Animals , Asia , Bacterial Proteins/genetics , Base Sequence , Cattle , Cattle Diseases/microbiology , Cattle Diseases/pathology , Comparative Genomic Hybridization , DNA, Bacterial/analysis , Drug Resistance, Bacterial/genetics , Hemorrhagic Septicemia/microbiology , Hemorrhagic Septicemia/pathology , High-Throughput Nucleotide Sequencing , Lipopolysaccharides/biosynthesis , Molecular Sequence Data , Pakistan , Pasteurella multocida/classification , Pasteurella multocida/isolation & purification , Phylogeny , Polymorphism, Single Nucleotide , Sequence Analysis, DNA
4.
Thromb Haemost ; 91(6): 1194-201, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15175807

ABSTRACT

Although the role of interleukin (IL)-6 in inflammatory diseases has been previously examined, its role in hemostasis, fibrinolysis, and coagulation during inflammation remains to be established. The present study elucidated the role of IL-6 in hemostatic and coagulatory changes during severe inflammation induced by intraperitoneal administration of lipopolysaccharide (LPS: 1 mg/kg) using IL-6 null (-/-) mice. After LPS challenge, IL-6 (-/-) mice revealed significant prolongation of prothrombin time and activated partial thromboplastin time and a significant decrease in platelet counts as compared with wild type mice. LPS treatment induced marked pulmonary hemorrhage with neutrophilic inflammation in IL-6 (-/-) mice, in contrast, only mild neutrophilic infiltration in WT mice confirmed by macroscopic and histological findings. The protein levels of proinflammatory mediators, such as IL-1 beta, macrophage inflammatory protein (MIP)-1 alpha, MIP-2, macrophage chemoattractant protein-1, granulocyte/macrophage-colony-stimulating factor, and keratinocyte chemoattractant in the lungs were significantly greater in IL-6 (-/-) mice than in WT mice after LPS challenge. These results directly indicate that IL-6 is protective against coagulatory and hemostatic disturbance and subsequent pulmonary hemorrhage induced by bacterial endotoxin, at least partly, via the modulation of proinflammatory processes.


Subject(s)
Hemostasis , Interleukin-6/physiology , Animals , Blood Coagulation/drug effects , Cytokines/blood , Fibrinolysis/drug effects , Genotype , Hemorrhagic Septicemia/blood , Hemorrhagic Septicemia/genetics , Hemostasis/drug effects , Inflammation , Interleukin-6/deficiency , Interleukin-6/genetics , Lipopolysaccharides/administration & dosage , Lung Diseases/blood , Lung Diseases/genetics , Lung Diseases/immunology , Mice , Mice, Knockout
SELECTION OF CITATIONS
SEARCH DETAIL